Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

Executive Summary

• Devonian Health Group filed two patent applications covering a proprietary “Thykamine™ fingerprint,” making it a core element of its long‑term IP strategy.
• The fingerprint defines eight specific chemical components in precise ratios, validated by HPLC‑MS, NMR, and potency assays showing ≥98% batch‑to‑batch consistency.
• These analytical controls will be incorporated into the Chemistry, Manufacturing & Controls (CMC) framework for Thykamine™ production, bolstering regulatory readiness and product quality assurance.

Key Details

• Patent Filings: Two recent applications formally disclose the proprietary Thykamine™ fingerprint; the filings are now part of Devonian’s core IP portfolio.
• Fingerprint Composition: Eight defined chemical components with exact ratios identified via advanced HPLC‑MS methods.
• Analytical Validation:
• HPLC‑MS methodology demonstrated high reproducibility across manufactured batches.
• Independent NMR analysis confirmed ≥98% confidence in batch‑to‑batch consistency.
• Biological Potency Assays:
• U‑937 human cell‑based model showed each batch consistently inhibits key inflammatory cytokines (RANTES, MIP‑1β).
• Assays are being validated for inclusion in the CMC section of Thykamine™ production dossiers.
• Regulatory Impact: The combined chemical fingerprinting, NMR confirmation, and potency data will form an integral part of Devonian’s CMC framework, supporting future regulatory submissions.
• CEO Quote: Dr. André Boulet emphasized that the integrated analytical approach ensures every batch of Thykamine™ delivers consistent quality, efficacy, and reliability for patients.

Notable Quotes

“These analytical and biological methods clearly demonstrate the quality and consistency of Thykamine™ produced in every batch— not only from a chemical standpoint, but also as an active anti‑inflammatory and anti‑fibrotic pharmaceutical.” – Dr. André Boulet, CEO, Devonian Health Group Inc.